OBJECTIVE: The purpose of this study was to determine whether G-CSF promotes coronary collateral growth (CCG) and decipher the mechanism for this stimulation. METHODS AND RESULTS: In a rat model of repetitive episodic myocardial ischemia (RI, 40 seconds LAD occlusion every 20 minutes for 2 hours and 20 minutes, 3 times/d for 5 days) CCG was deduced from collateral-dependent flow (flow to LAD region during occlusion). After RI, G-CSF (100 microg/kg/d) increased CCG (P<0.01) (0.47+/-0.15) versus vehicle (0.14+/-0.06). Surprisingly, G-CSF treatment without RI increased CCG (0.57+/-0.18) equal to G-CSF+RI. We evaluated ROS by dihydroethidine (DHE) fluorescence (LV injection, 60 microg/kg, during two episodes of ischemia). DHE fluorescence was double in G-CSF+RI versus vehicle+RI (P<0.01), and even higher in G-CSF without RI (P<0.01). Interestingly, the DHE signal did not colocalize with myeloperoxidase (immunostaining, neutrophil marker) but appeared in cardiac myocytes. The study of isolated cardiac myocytes revealed the cytokine stimulates ROS which elicit production of angiogenic factors. Apocynin inhibited G-CSF effects both in vivo and in vitro. CONCLUSIONS: G-CSF stimulates ROS production directly in cardiomyocytes, which plays a pivotal role in triggering adaptations of the heart to ischemia including growth of the coronary collaterals.
OBJECTIVE: The purpose of this study was to determine whether G-CSF promotes coronary collateral growth (CCG) and decipher the mechanism for this stimulation. METHODS AND RESULTS: In a rat model of repetitive episodic myocardial ischemia (RI, 40 seconds LAD occlusion every 20 minutes for 2 hours and 20 minutes, 3 times/d for 5 days) CCG was deduced from collateral-dependent flow (flow to LAD region during occlusion). After RI, G-CSF (100 microg/kg/d) increased CCG (P<0.01) (0.47+/-0.15) versus vehicle (0.14+/-0.06). Surprisingly, G-CSF treatment without RI increased CCG (0.57+/-0.18) equal to G-CSF+RI. We evaluated ROS by dihydroethidine (DHE) fluorescence (LV injection, 60 microg/kg, during two episodes of ischemia). DHE fluorescence was double in G-CSF+RI versus vehicle+RI (P<0.01), and even higher in G-CSF without RI (P<0.01). Interestingly, the DHE signal did not colocalize with myeloperoxidase (immunostaining, neutrophil marker) but appeared in cardiac myocytes. The study of isolated cardiac myocytes revealed the cytokine stimulates ROS which elicit production of angiogenic factors. Apocynin inhibited G-CSF effects both in vivo and in vitro. CONCLUSIONS:G-CSF stimulates ROS production directly in cardiomyocytes, which plays a pivotal role in triggering adaptations of the heart to ischemia including growth of the coronary collaterals.
Authors: M Sattler; S Verma; G Shrikhande; C H Byrne; Y B Pride; T Winkler; E A Greenfield; R Salgia; J D Griffin Journal: J Biol Chem Date: 2000-08-11 Impact factor: 5.157
Authors: Ibrahim R Hanna; Yoshihiro Taniyama; Katalin Szöcs; Petra Rocic; Kathy K Griendling Journal: Antioxid Redox Signal Date: 2002-12 Impact factor: 8.401
Authors: S Nagata; M Tsuchiya; S Asano; Y Kaziro; T Yamazaki; O Yamamoto; Y Hirata; N Kubota; M Oheda; H Nomura Journal: Nature Date: 1986 Jan 30-Feb 5 Impact factor: 49.962
Authors: Gregory Joseph; Amanda Soler; Rebecca Hutcheson; Ian Hunter; Chastity Bradford; Brenda Hutcheson; Katherine H Gotlinger; Houli Jiang; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Petra Rocic Journal: Am J Physiol Heart Circ Physiol Date: 2016-12-23 Impact factor: 4.733
Authors: Yuh Fen Pung; Petra Rocic; Michael P Murphy; Robin A J Smith; Jennifer Hafemeister; Vahagn Ohanyan; Giacinta Guarini; Liya Yin; William M Chilian Journal: Arterioscler Thromb Vasc Biol Date: 2011-12-08 Impact factor: 8.311
Authors: Nora Gatzke; Philipp Hillmeister; André Dülsner; Nadija Güc; Rica Dawid; Katherine H Smith; Nikolaos Pagonas; Peter Bramlage; Michaela Gorath; Ivo R Buschmann Journal: PLoS One Date: 2018-08-17 Impact factor: 3.240